MX2022003589A - Lactobacillus reuteri. - Google Patents

Lactobacillus reuteri.

Info

Publication number
MX2022003589A
MX2022003589A MX2022003589A MX2022003589A MX2022003589A MX 2022003589 A MX2022003589 A MX 2022003589A MX 2022003589 A MX2022003589 A MX 2022003589A MX 2022003589 A MX2022003589 A MX 2022003589A MX 2022003589 A MX2022003589 A MX 2022003589A
Authority
MX
Mexico
Prior art keywords
strain
lactobacillus reuteri
raffinose
administered
separately
Prior art date
Application number
MX2022003589A
Other languages
English (en)
Inventor
Jens Walter
Original Assignee
Prec Group Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Prec Group Limited filed Critical Prec Group Limited
Publication of MX2022003589A publication Critical patent/MX2022003589A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/125—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives containing carbohydrate syrups; containing sugars; containing sugar alcohols; containing starch hydrolysates
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00—Lactic or propionic acid bacteria
    • A23V2400/11—Lactobacillus
    • A23V2400/173—Reuteri
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K2035/11—Medicinal preparations comprising living procariotic cells
    • A61K2035/115—Probiotics
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/225—Lactobacillus

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Virology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Botany (AREA)
  • Pediatric Medicine (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

La cepa Lactobacillus reuteri que tiene el número de acceso NCIMB 42835 es de un cladofilogenético novedoso y tiene propiedades únicas inmunoestimulatorias y comportamiento ecológico mejorado en el intestino humano. Un sustrato para la cepa, como rafinosa, puede ser administrado al mismo tiempo o separadamente a partir de la cepa.
MX2022003589A 2019-09-26 2020-09-24 Lactobacillus reuteri. MX2022003589A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP19199823 2019-09-26
EP20161520 2020-03-06
PCT/EP2020/076792 WO2021058688A1 (en) 2019-09-26 2020-09-24 Lactobacillus reuteri

Publications (1)

Publication Number Publication Date
MX2022003589A true MX2022003589A (es) 2022-07-19

Family

ID=72561817

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2022003589A MX2022003589A (es) 2019-09-26 2020-09-24 Lactobacillus reuteri.

Country Status (8)

Country Link
US (1) US20230146454A1 (es)
EP (1) EP4034681A1 (es)
KR (1) KR20220066269A (es)
CN (1) CN114269897A (es)
AU (1) AU2020352646A1 (es)
BR (1) BR112022005756A2 (es)
MX (1) MX2022003589A (es)
WO (1) WO2021058688A1 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102606078B1 (ko) * 2021-05-07 2023-11-24 주식회사 브이원바이오 리모실락토바실러스 루테리 va102 및 이를 함유하는 항암용 조성물

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK1567018T3 (da) * 2002-10-18 2009-09-14 Biogaia Ab Fremgangsmåde til at forbedre immunfunktionen hos pattedyr ved anvendelse af lactobacillus reuteri stammer
US20120207713A1 (en) * 2007-03-28 2012-08-16 Alimentary Health Limited Probiotic bifidobacterium strains
US20080254011A1 (en) * 2007-04-11 2008-10-16 Peter Rothschild Use of selected lactic acid bacteria for reducing atherosclerosis
US10624934B2 (en) * 2014-03-06 2020-04-21 Research Institute At Nationwide Children's Hospital Prebiotic formulations
CA2972967A1 (en) * 2015-01-16 2016-07-21 Biogaia Ab Lactic acid bacteria and their use for the treatment of mastitis
WO2018115361A1 (en) * 2016-12-21 2018-06-28 Agriculture And Food Development Authority (Teagasc) Human lactobacilli strains

Also Published As

Publication number Publication date
KR20220066269A (ko) 2022-05-24
AU2020352646A1 (en) 2022-03-24
CN114269897A (zh) 2022-04-01
EP4034681A1 (en) 2022-08-03
BR112022005756A2 (pt) 2022-09-06
WO2021058688A1 (en) 2021-04-01
US20230146454A1 (en) 2023-05-11

Similar Documents

Publication Publication Date Title
NZ742787A (en) Compositions comprising bacterial strains
MX2012005524A (es) Cepa de probioticos bifidobacterium.
PT2173196E (pt) Uso de probi?ticos e fibras para a diarreia
CL2009000649A1 (es) Cepa de lactobacillus rhamnosus cncm i-3690 con propiedades antimicrobianas e inmunomoduladoras; fraccion celular de la misma; y composicion que la comprende.
PH12015500091B1 (en) Non-pathogenic f18 e.coli strain and use thereof
WO2008053444A3 (en) Treating a respiratory condition with bifidobacterium
TW200745283A (en) Polymeric materials
TNSN06022A1 (en) Use of calcitonin in osteoarthritis
DK1883695T3 (da) Probiotisk bifidobakterieart
EP3927820A4 (en) LACHNOSPIRACEAE BACTERIUM ND2006 CAS12A MUTANT GENES AND POLYPEPTIDES ENCODED BY THEM
MX2013002533A (es) Material flexible y articulos fabricados del mismo.
NZ596722A (en) A temperature sensitive vaccine strain of mycoplasma hyopneumoniae and uses thereof
TW200740856A (en) Synthetic rubber with narrow molecular weight distribution, its use and a process for its preparation
RS54478B1 (en) LACTOBACILLUS PLANTARUM MCC1 DSM 23881 ISOLATED MICRO-ORGANISM AND ITS USE
TW200634087A (en) Block copolymer mixture and heat shrinkable film using the same
MY193248A (en) Novel probiotic bacterial strain of lactobacillus plantarum and compositions and uses thereof in the treatment of inflammation
SG11202000123SA (en) Lactobacillus plantarum cjlp475 strain having antiviral and immunomodulatory effects and composition comprising the same
MX2017015674A (es) Suplemento dietetico.
TW200801167A (en) Polishing composition
PH12019502699A1 (en) Composition comprising lactobacillus plantarum cjlp475 strain and lactobacillus plantarum cjlp17 strain and use thereof
IL289610A (en) Bacterial strain Bifidobacterium bifidum, its preparations and related uses
MX339753B (es) Composiciones vulcanizables basadas en cauchos de nitrilo que contienen grupos epoxi.
MX2022003589A (es) Lactobacillus reuteri.
UA94056C2 (uk) Застосування специфічних молочнокислих бактерій для одержання імуномодулюючих композицій
AU2018410430A1 (en) Lactobacillus reuteri SS23-52, preparation method of dry powder starter thereof, and application thereof in purebred probiotic yogurt